These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 35095907)

  • 21. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
    Saunders KO; Lee E; Parks R; Martinez DR; Li D; Chen H; Edwards RJ; Gobeil S; Barr M; Mansouri K; Alam SM; Sutherland LL; Cai F; Sanzone AM; Berry M; Manne K; Bock KW; Minai M; Nagata BM; Kapingidza AB; Azoitei M; Tse LV; Scobey TD; Spreng RL; Rountree RW; DeMarco CT; Denny TN; Woods CW; Petzold EW; Tang J; Oguin TH; Sempowski GD; Gagne M; Douek DC; Tomai MA; Fox CB; Seder R; Wiehe K; Weissman D; Pardi N; Golding H; Khurana S; Acharya P; Andersen H; Lewis MG; Moore IN; Montefiori DC; Baric RS; Haynes BF
    Nature; 2021 Jun; 594(7864):553-559. PubMed ID: 33971664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
    Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
    Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
    [No Abstract]   [Full Text] [Related]  

  • 23. A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.
    Augusto DG; Murdolo LD; Chatzileontiadou DSM; Sabatino JJ; Yusufali T; Peyser ND; Butcher X; Kizer K; Guthrie K; Murray VW; Pae V; Sarvadhavabhatla S; Beltran F; Gill GS; Lynch KL; Yun C; Maguire CT; Peluso MJ; Hoh R; Henrich TJ; Deeks SG; Davidson M; Lu S; Goldberg SA; Kelly JD; Martin JN; Vierra-Green CA; Spellman SR; Langton DJ; Dewar-Oldis MJ; Smith C; Barnard PJ; Lee S; Marcus GM; Olgin JE; Pletcher MJ; Maiers M; Gras S; Hollenbach JA
    Nature; 2023 Aug; 620(7972):128-136. PubMed ID: 37468623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19?
    Finotti P
    Cell Stress Chaperones; 2022 Jan; 27(1):37-43. PubMed ID: 34755305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria.
    Eggenhuizen PJ; Ng BH; Chang J; Cheong RMY; Yellapragada A; Wong WY; Ting YT; Monk JA; Gan PY; Holdsworth SR; Ooi JD
    Front Immunol; 2022; 13():821595. PubMed ID: 35154139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
    Khade SM; Yabaji SM; Srivastava J
    Prep Biochem Biotechnol; 2021; 51(7):650-658. PubMed ID: 33226885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents.
    Wang X; Zhang J; Liu M; Guo Y; Guo P; Yang X; Shang B; Li M; Tian J; Zhang T; Wang X; Jin R; Zhou J; Gao GF; Liu J
    Signal Transduct Target Ther; 2024 Jun; 9(1):160. PubMed ID: 38866784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
    Hupert N; Marín-Hernández D; Gao B; Águas R; Nixon DF
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterologous vaccine interventions: boosting immunity against future pandemics.
    Marín-Hernández D; Nixon DF; Hupert N
    Mol Med; 2021 May; 27(1):54. PubMed ID: 34058986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
    Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.
    Gong W; Mao Y; Li Y; Qi Y
    Int Immunopharmacol; 2022 Jul; 108():108870. PubMed ID: 35597119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCG Vaccine, A Ray of Hope in Treating Severe Acute Respiratory Syndrome (SARS).
    Banerjee AB; Singh TG; Prashar A
    Infect Disord Drug Targets; 2021; 21(5):e270421186935. PubMed ID: 33069201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2.
    Piadel K; Haybatollahi A; Dalgleish AG; Smith PL
    J Gen Virol; 2022 Jan; 103(1):. PubMed ID: 35014605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection.
    Chowdhury UN; Faruqe MO; Mehedy M; Ahmad S; Islam MB; Shoombuatong W; Azad AKM; Moni MA
    Comput Biol Med; 2021 Nov; 138():104891. PubMed ID: 34624759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.